WellTheory

On a mission to reverse the autoimmune epidemic

Atherton, United States · Founded 2022 · $14.0M raised

Employees
11–50
Founded
2022
Business Model
B2B2C
Total Funding
$14.0M
Last Round
$14.0M Extension RoundOct 2025
Rounds
1

About

WellTheory is an AI-powered care platform built for autoimmune patients, offering whole-person care through a blend of clinical, nutritional, and lifestyle support. Members are paired with registered dietitians and health coaches who create personalized nutrition and lifestyle plans informed by root cause analysis. The platform also offers an enterprise offering to employers and health plans seeking to reduce autoimmune-related healthcare costs. Founded by Ellen Rudolph, who navigated her own autoimmune health journey, WellTheory launched in 2022 and has been recognized as one of Fast Company's Most Innovative Health Companies of 2024.

Summary

WellTheory is a Life Sciences company based in Atherton, United States, founded in 2022. It has raised $14.0M in total across 1 round, most recently a $14.0M Extension Round round in Oct 2025. Investors include General Catalyst and Accel.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Extension RoundExtension RoundOct 2025
$14.0M

Investors

Similar Companies